(Q35642789)

9 August 2017

1 reference

title

Concurrent chemoradiotherapy for clinical stage T2 bladder cancer: report of a single institution (English)

1 reference

9 August 2017

0 references

3

Philippe Beuzeboc

1 reference

9 August 2017

1

Michaël Peyromaure

1 reference

9 August 2017

5

Bernard Debré

1 reference

9 August 2017

Jerôme Slama

2

1 reference

9 August 2017

Dominique Ponvert

series ordinal

4

1 reference

9 August 2017

Marc Zerbib

series ordinal

6

1 reference

9 August 2017

language of work or name

English

0 references

publication date

1 January 2004

1 reference

9 August 2017

1 reference

9 August 2017

volume

63

1 reference

9 August 2017

issue

1

1 reference

9 August 2017

page(s)

73-77

1 reference

Radical cystectomy in the treatment of invasive bladder cancer: long-term results in 1,054 patients.

9 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLOGY.2003.09.018

Analysis of early complications after radical cystectomy: results of a collaborative care pathway

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLOGY.2003.09.018

Assessment of morbidity and functional results in bladder replacement with Hautmann ileal neobladder after radical cystectomy: a clinical experience in 55 highly selected patients

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLOGY.2003.09.018

Combined radiation and chemotherapy for invasive transitional-cell carcinoma of the bladder: a prospective study

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLOGY.2003.09.018

Concurrent cisplatin and radiotherapy for patients with muscle invasive bladder cancer who are not candidates for radical cystectomy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLOGY.2003.09.018

Combined chemotherapy and radiation with selective organ preservation for muscle-invasive bladder carcinoma. A single-institution phase II study

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLOGY.2003.09.018

Chemoradiotherapy for muscle invading bladder carcinoma. Final report of a single institutional organ-sparing program.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLOGY.2003.09.018

Combined-modality treatment and selective organ preservation in invasive bladder cancer: long-term results

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLOGY.2003.09.018

Selective bladder preservation by combined modality protocol treatment: long-term outcomes of 190 patients with invasive bladder cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLOGY.2003.09.018

Second resection and prognosis of primary high risk superficial bladder cancer: is cystectomy often too early?

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLOGY.2003.09.018

The value of a second transurethral resection in evaluating patients with bladder tumors

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLOGY.2003.09.018

Hypofractionated radiotherapy for invasive bladder cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLOGY.2003.09.018

Muscle-invasive bladder cancer treated with external beam radiotherapy: pretreatment prognostic factors and the predictive value of cystoscopic re-evaluation during treatment

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLOGY.2003.09.018

Transurethral resection of muscle-invasive bladder cancer: 10-year outcome

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLOGY.2003.09.018

10.1016/J.UROLOGY.2003.09.018

7 January 2021

Identifiers

DOI

1 reference

9 August 2017

1 reference